PMDA Issues Guidance on COVID-19 Vaccines’ Immunogenicity Assessment for Non-Placebo-Controlled Trials

The Pharmaceuticals and Medical Devices Agency (PMDA) on October 22 issued guidance on the implantation of confirmatory clinical trials without placebo groups to develop new COVID-19 vaccines, detailing points to bear in mind when evaluating efficacy based on immunogenicity-related markers...read more